Copyright Reports & Markets. All rights reserved.

Global Parkinsons disease Drug Sales Market Report 2021

Request for Sample of this report
Buy now

1 Parkinsons disease Drug Market Overview

  • 1.1 Parkinsons disease Drug Product Scope
  • 1.2 Parkinsons disease Drug Segment by Type
    • 1.2.1 Global Parkinsons disease Drug Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Carbidopa/Levodopa
    • 1.2.3 Dopamine Receptor Agonists
    • 1.2.4 MAO-Inhibitors
  • 1.3 Parkinsons disease Drug Segment by Application
    • 1.3.1 Global Parkinsons disease Drug Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital
    • 1.3.3 Online
    • 1.3.4 Retail Pharmacies
  • 1.4 Parkinsons disease Drug Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Parkinsons disease Drug Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Parkinsons disease Drug Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Parkinsons disease Drug Price Trends (2016-2027)

2 Parkinsons disease Drug Estimates and Forecasts by Region

  • 2.1 Global Parkinsons disease Drug Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Parkinsons disease Drug Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Parkinsons disease Drug Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Parkinsons disease Drug Revenue Market Share by Region (2016-2021)
  • 2.3 Global Parkinsons disease Drug Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Parkinsons disease Drug Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Parkinsons disease Drug Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Parkinsons disease Drug Estimates and Projections (2016-2027)
    • 2.4.2 Europe Parkinsons disease Drug Estimates and Projections (2016-2027)
    • 2.4.3 China Parkinsons disease Drug Estimates and Projections (2016-2027)
    • 2.4.4 Japan Parkinsons disease Drug Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Parkinsons disease Drug Estimates and Projections (2016-2027)
    • 2.4.6 India Parkinsons disease Drug Estimates and Projections (2016-2027)

3 Global Parkinsons disease Drug Competition Landscape by Players

  • 3.1 Global Top Parkinsons disease Drug Players by Sales (2016-2021)
  • 3.2 Global Top Parkinsons disease Drug Players by Revenue (2016-2021)
  • 3.3 Global Parkinsons disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons disease Drug as of 2020)
  • 3.4 Global Parkinsons disease Drug Average Price by Company (2016-2021)
  • 3.5 Manufacturers Parkinsons disease Drug Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Parkinsons disease Drug Market Size by Type

  • 4.1 Global Parkinsons disease Drug Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Parkinsons disease Drug Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Parkinsons disease Drug Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Parkinsons disease Drug Price by Type (2016-2021)
  • 4.2 Global Parkinsons disease Drug Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Parkinsons disease Drug Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Parkinsons disease Drug Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Parkinsons disease Drug Price Forecast by Type (2022-2027)

5 Global Parkinsons disease Drug Market Size by Application

  • 5.1 Global Parkinsons disease Drug Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Parkinsons disease Drug Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Parkinsons disease Drug Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Parkinsons disease Drug Price by Application (2016-2021)
  • 5.2 Global Parkinsons disease Drug Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Parkinsons disease Drug Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Parkinsons disease Drug Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Parkinsons disease Drug Price Forecast by Application (2022-2027)

6 North America Parkinsons disease Drug Market Facts & Figures

  • 6.1 North America Parkinsons disease Drug Sales by Company
    • 6.1.1 North America Parkinsons disease Drug Sales by Company (2016-2021)
    • 6.1.2 North America Parkinsons disease Drug Revenue by Company (2016-2021)
  • 6.2 North America Parkinsons disease Drug Sales Breakdown by Type
    • 6.2.1 North America Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Parkinsons disease Drug Sales Breakdown by Type (2022-2027)
  • 6.3 North America Parkinsons disease Drug Sales Breakdown by Application
    • 6.3.1 North America Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Parkinsons disease Drug Sales Breakdown by Application (2022-2027)

7 Europe Parkinsons disease Drug Market Facts & Figures

  • 7.1 Europe Parkinsons disease Drug Sales by Company
    • 7.1.1 Europe Parkinsons disease Drug Sales by Company (2016-2021)
    • 7.1.2 Europe Parkinsons disease Drug Revenue by Company (2016-2021)
  • 7.2 Europe Parkinsons disease Drug Sales Breakdown by Type
    • 7.2.1 Europe Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Parkinsons disease Drug Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Parkinsons disease Drug Sales Breakdown by Application
    • 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Parkinsons disease Drug Market Facts & Figures

  • 8.1 China Parkinsons disease Drug Sales by Company
    • 8.1.1 China Parkinsons disease Drug Sales by Company (2016-2021)
    • 8.1.2 China Parkinsons disease Drug Revenue by Company (2016-2021)
  • 8.2 China Parkinsons disease Drug Sales Breakdown by Type
    • 8.2.1 China Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Parkinsons disease Drug Sales Breakdown by Type (2022-2027)
  • 8.3 China Parkinsons disease Drug Sales Breakdown by Application
    • 8.3.1 China 312 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Parkinsons disease Drug Market Facts & Figures

  • 9.1 Japan Parkinsons disease Drug Sales by Company
    • 9.1.1 Japan Parkinsons disease Drug Sales by Company (2016-2021)
    • 9.1.2 Japan Parkinsons disease Drug Revenue by Company (2016-2021)
  • 9.2 Japan Parkinsons disease Drug Sales Breakdown by Type
    • 9.2.1 Japan Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Parkinsons disease Drug Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Parkinsons disease Drug Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Parkinsons disease Drug Market Facts & Figures

  • 10.1 Southeast Asia Parkinsons disease Drug Sales by Company
    • 10.1.1 Southeast Asia Parkinsons disease Drug Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Parkinsons disease Drug Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Parkinsons disease Drug Sales Breakdown by Type
    • 10.2.1 Southeast Asia Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Parkinsons disease Drug Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Parkinsons disease Drug Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Parkinsons disease Drug Market Facts & Figures

  • 11.1 India Parkinsons disease Drug Sales by Company
    • 11.1.1 India Parkinsons disease Drug Sales by Company (2016-2021)
    • 11.1.2 India Parkinsons disease Drug Revenue by Company (2016-2021)
  • 11.2 India Parkinsons disease Drug Sales Breakdown by Type
    • 11.2.1 India Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Parkinsons disease Drug Sales Breakdown by Type (2022-2027)
  • 11.3 India Parkinsons disease Drug Sales Breakdown by Application
    • 11.3.1 India Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Parkinsons disease Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Parkinsons disease Drug Business

  • 12.1 Teva
    • 12.1.1 Teva Corporation Information
    • 12.1.2 Teva Business Overview
    • 12.1.3 Teva Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Teva Parkinsons disease Drug Products Offered
    • 12.1.5 Teva Recent Development
  • 12.2 Novartis AG
    • 12.2.1 Novartis AG Corporation Information
    • 12.2.2 Novartis AG Business Overview
    • 12.2.3 Novartis AG Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Novartis AG Parkinsons disease Drug Products Offered
    • 12.2.5 Novartis AG Recent Development
  • 12.3 GSK
    • 12.3.1 GSK Corporation Information
    • 12.3.2 GSK Business Overview
    • 12.3.3 GSK Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 GSK Parkinsons disease Drug Products Offered
    • 12.3.5 GSK Recent Development
  • 12.4 AbbVie
    • 12.4.1 AbbVie Corporation Information
    • 12.4.2 AbbVie Business Overview
    • 12.4.3 AbbVie Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 AbbVie Parkinsons disease Drug Products Offered
    • 12.4.5 AbbVie Recent Development
  • 12.5 Merck
    • 12.5.1 Merck Corporation Information
    • 12.5.2 Merck Business Overview
    • 12.5.3 Merck Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Merck Parkinsons disease Drug Products Offered
    • 12.5.5 Merck Recent Development
  • 12.6 Boehringer Ingelheim
    • 12.6.1 Boehringer Ingelheim Corporation Information
    • 12.6.2 Boehringer Ingelheim Business Overview
    • 12.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Boehringer Ingelheim Parkinsons disease Drug Products Offered
    • 12.6.5 Boehringer Ingelheim Recent Development
  • 12.7 Impax Laboratories
    • 12.7.1 Impax Laboratories Corporation Information
    • 12.7.2 Impax Laboratories Business Overview
    • 12.7.3 Impax Laboratories Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Impax Laboratories Parkinsons disease Drug Products Offered
    • 12.7.5 Impax Laboratories Recent Development
  • 12.8 Lundbeck
    • 12.8.1 Lundbeck Corporation Information
    • 12.8.2 Lundbeck Business Overview
    • 12.8.3 Lundbeck Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Lundbeck Parkinsons disease Drug Products Offered
    • 12.8.5 Lundbeck Recent Development
  • 12.9 Sun Pharma
    • 12.9.1 Sun Pharma Corporation Information
    • 12.9.2 Sun Pharma Business Overview
    • 12.9.3 Sun Pharma Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Sun Pharma Parkinsons disease Drug Products Offered
    • 12.9.5 Sun Pharma Recent Development
  • 12.10 Wockhardt
    • 12.10.1 Wockhardt Corporation Information
    • 12.10.2 Wockhardt Business Overview
    • 12.10.3 Wockhardt Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Wockhardt Parkinsons disease Drug Products Offered
    • 12.10.5 Wockhardt Recent Development
  • 12.11 UCB
    • 12.11.1 UCB Corporation Information
    • 12.11.2 UCB Business Overview
    • 12.11.3 UCB Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 UCB Parkinsons disease Drug Products Offered
    • 12.11.5 UCB Recent Development
  • 12.12 Bausch Health
    • 12.12.1 Bausch Health Corporation Information
    • 12.12.2 Bausch Health Business Overview
    • 12.12.3 Bausch Health Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Bausch Health Parkinsons disease Drug Products Offered
    • 12.12.5 Bausch Health Recent Development
  • 12.13 Acadia
    • 12.13.1 Acadia Corporation Information
    • 12.13.2 Acadia Business Overview
    • 12.13.3 Acadia Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Acadia Parkinsons disease Drug Products Offered
    • 12.13.5 Acadia Recent Development

13 Parkinsons disease Drug Manufacturing Cost Analysis

  • 13.1 Parkinsons disease Drug Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Parkinsons disease Drug
  • 13.4 Parkinsons disease Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Parkinsons disease Drug Distributors List
  • 14.3 Parkinsons disease Drug Customers

15 Market Dynamics

  • 15.1 Parkinsons disease Drug Market Trends
  • 15.2 Parkinsons disease Drug Drivers
  • 15.3 Parkinsons disease Drug Market Challenges
  • 15.4 Parkinsons disease Drug Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Parkinsons disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Carbidopa/Levodopa
    Dopamine Receptor Agonists
    MAO-Inhibitors

    Segment by Application
    Hospital
    Online
    Retail Pharmacies

    The Parkinsons disease Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Parkinsons disease Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Teva
    Novartis AG
    GSK
    AbbVie
    Merck
    Boehringer Ingelheim
    Impax Laboratories
    Lundbeck
    Sun Pharma
    Wockhardt
    UCB
    Bausch Health
    Acadia

    Buy now